IR
Superintel
Overview
Markets
Watchlist
More
Idenix Pharmaceuticals Inc
CUSIP: 45166R954 | 4 institutional holders
Watch
Quarters
Q2 2014
Q1 2014
Q4 2013
Q3 2013
Q2 2013
Compare
Detailed
Historical
Funds
Options
Short Interest
13D/13G
Peers
Targeting
Trading Summary
Profile